FDA Drug recall D-0667-2017
Lumigan (bimatoprost ophthalmic solution) 0.01%, 7.5 mL bottle, Rx only, Allergan Irvine, CA 92612, NDC 0023-3205-08
- FDA Drug
- Class III
- terminated
- Published 2017-04-19
On 2017-04-19 the FDA classified a Class III recall of Lumigan (bimatoprost ophthalmic solution) 0.01%, 7.5 mL bottle, Rx only, Allergan Irvine, CA 92612, NDC 0023-3205-08 by Allergan Sales, citing failed Impurities/Degradation Specifications.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0667-2017 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2017-03-16 |
| Published | 2017-04-19 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Allergan Sales |
| Distribution | US |
Product
Lumigan (bimatoprost ophthalmic solution) 0.01%, 7.5 mL bottle, Rx only, Allergan Irvine, CA 92612, NDC 0023-3205-08.
Reason
Failed Impurities/Degradation Specifications
Identifiers
| ndc | 0023-3205-02 |
|---|---|
| ndc | 0023-3205-03 |
| ndc | 0023-3205-05 |
| ndc | 0023-3205-08 |
| code_info | Lot #: 92577, Exp. JUN 2018 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0667-2017%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.